These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18026201)

  • 1. Bevacizumab in glaucoma: a review.
    Ichhpujani P; Ramasubramanian A; Kaushik S; Pandav SS
    Can J Ophthalmol; 2007 Dec; 42(6):812-5. PubMed ID: 18026201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
    Mason JO; Albert MA; Mays A; Vail R
    Retina; 2006 Sep; 26(7):839-41. PubMed ID: 16963866
    [No Abstract]   [Full Text] [Related]  

  • 3. Bevacizumab (Avastin) for the treatment of neovascular glaucoma.
    Chilov MN; Grigg JR; Playfair TJ
    Clin Exp Ophthalmol; 2007 Jul; 35(5):494-6. PubMed ID: 17651259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
    dell'Omo R; Kulkarni A; Franks WA
    Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
    [No Abstract]   [Full Text] [Related]  

  • 5. Intracameral bevacizumab for iris rubeosis.
    Grisanti S; Biester S; Peters S; Tatar O; Ziemssen F; Bartz-Schmidt KU;
    Am J Ophthalmol; 2006 Jul; 142(1):158-60. PubMed ID: 16815268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Intravitreal Bevacizumab Injection on Iris and Iridocorneal Angle Neovascularization in Neovascular Glaucoma].
    Ishibashi S; Kondo H
    J UOEH; 2015 Dec; 37(4):299-304. PubMed ID: 26667197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab (avastin) in ocular processes other than choroidal neovascularization.
    Barkmeier AJ; Akduman L
    Ocul Immunol Inflamm; 2009; 17(2):109-17. PubMed ID: 19412873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
    Batioğlu F; Astam N; Ozmert E
    Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma.
    Chalam KV; Gupta SK; Grover S; Brar VS; Agarwal S
    Eur J Ophthalmol; 2008; 18(2):255-62. PubMed ID: 18320519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma.
    Wasik A; Song HF; Grimes A; Engelke C; Thomas A
    Optometry; 2009 May; 80(5):243-8. PubMed ID: 19410229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.
    Kim M; Lee C; Payne R; Yue BY; Chang JH; Ying H
    Surv Ophthalmol; 2015; 60(6):524-35. PubMed ID: 25980779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical session: neovascular glaucoma and anti-vascular endothelial growth factor treatment].
    Laplace O
    J Fr Ophtalmol; 2009 Mar; 32(3):230-5. PubMed ID: 19515340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.
    Silva Paula J; Jorge R; Alves Costa R; Rodrigues Mde L; Scott IU
    Acta Ophthalmol Scand; 2006 Aug; 84(4):556-7. PubMed ID: 16879583
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab.
    Lupinacci AP; Calzada JI; Rafieetery M; Charles S; Netland PA
    Adv Ther; 2009 Feb; 26(2):208-16. PubMed ID: 19234680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
    Ishibashi S; Tawara A; Sohma R; Kubota T; Toh N
    Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma.
    Vásquez LM; Somani S; Altomare F; Simpson ER
    Can J Ophthalmol; 2009 Feb; 44(1):106-7. PubMed ID: 19169330
    [No Abstract]   [Full Text] [Related]  

  • 18. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
    Duch S; Buchacra O; Milla E; Andreu D; Tellez J
    J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
    Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
    Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical bevacizumab for neovascular glaucoma: a pilot study.
    Waisbourd M; Shemesh G; Kurtz S; Rachmiel R; Moisseiev E; Zayit-Soudri S; Loewenstein A; Barequet I
    Pharmacology; 2014; 93(3-4):108-12. PubMed ID: 24556733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.